Healthcare - Biotechnology - NASDAQ - US
$ 0.3397
-2.92 %
$ 5.87 M
Market Cap
0.0
P/E
BALANCE SHEET
5.17 M
ASSETS
3.53 M
LIABILITIES
1.64 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
TransCode Therapeutics, Inc.
| Current Assets | 4.46 M |
| Cash & Short-Term Investments | 2.77 M |
| Receivables | 0 |
| Other Current Assets | 1.69 M |
| Non-Current Assets | 714 K |
| Long-Term Investments | 0 |
| PP&E | 602 K |
| Other Non-Current Assets | 112 K |
| Current Liabilities | 3.49 M |
| Accounts Payable | 0 |
| Short-Term Debt | 412 K |
| Other Current Liabilities | 3.08 M |
| Non-Current Liabilities | 38.3 K |
| Long-Term Debt | 38.3 K |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 2.8 | 5.0 | 20.8 | 0.8 | 0.2 | 0.2 |
| Short Term Investments | 0 | 9.41 | 9.41 | 3.2 | 0 | 0 |
| Receivables | 0 | 0.4 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0.6 | 0 | 0 | 0 | 0 |
| Other Current Assets | 1.7 | 2.1 | 1.9 | 3.2 K | 0 | 1.67 K |
| Total Current Assets | 4.5 | 7.4 | 22.7 | 0.8 | 0.2 | 0.2 |
| PP&E | 0.6 | 0.2 | 0.2 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 12.8 K | 12.3 K | 0 |
| Other Long Term Assets | 0.1 | 0 | 0 | 0.2 | 1 | 0 |
| Other Assets | 1 | 0 | 0 | 0 | 12.3 K | 0 |
| Total Assets | 5.2 | 7.6 | 22.9 | 1.1 | 0.2 | 0.2 |
| LIABILITIES | ||||||
| Accounts Payable | 0 | 4.3 | 2.0 | 0 | 0 | 0 |
| Short Term Debt | 0.4 | 0 | 0 | 0 | 0 | 35.7 K |
| Other Current Liabilities | 3.1 | 0 | 0.5 | 0.4 | 62.9 K | 82 K |
| Total Current Liabilities | 3.5 | 4.3 | 2.5 | 0.4 | 62.9 K | 0.1 |
| Long Term Debt | 38.3 K | 0 | 0 | 2.1 | 0.9 | 0.4 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 2.0 | 0.3 | 0.2 |
| Total Liabilities | 3.5 | 4.3 | 2.5 | 4.5 | 1.3 | 0.7 |
| EQUITY | ||||||
| Common Stock | 63 | 1.3 K | 1.29 K | 464 | 464 | 764 |
| Retained Earnings | (46.4) | (27.9) | (10.3) | (3.5) | (1.1) | (0.5) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | 0 | 12.8 | 12.3 | 11.8 K |
| Total Equity | 1.6 | 3.2 | 20.4 | (3.4) | (1.1) | (0.5) |
| Total Liabilities and Equity | 5.2 | 7.6 | 22.9 | 1.1 | 0.2 | 0.2 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 0.2 | 16 K | 10.5 K | 7.98 K | 6.41 K | 6.41 K |